Cunnington, C., Van Assche, T., Shirodaria, C., Kylintireas, I., Lindsay, A., Ratnatunga, C., Pillai, R., Choudhury, R., Neubauer, S., & Channon, K. (2016). Chronic oral tetrahydrobiopterin therapy in coronary artery disease elevates total biopterin levels but does not improve redox status or vascular function: a randomized placebo-controlled trial. 31, 390–390.

Cunnington, C., et al. Chronic Oral Tetrahydrobiopterin Therapy in Coronary Artery Disease Elevates Total Biopterin Levels but Does Not Improve Redox Status or Vascular Function: a Randomized Placebo-Controlled Trial. 2016, pp. 390–90.

Cunnington, C, T Van Assche, C Shirodaria, I Kylintireas, A Lindsay, C Ratnatunga, R Pillai, R Choudhury, S Neubauer, and K Channon. 2016. “Chronic Oral Tetrahydrobiopterin Therapy in Coronary Artery Disease Elevates Total Biopterin Levels but Does Not Improve Redox Status or Vascular Function: a Randomized Placebo-Controlled Trial.” In , 31:390–90.